KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Novavax (NVAX) Return on Capital Employed (2016 - 2025)

Novavax (NVAX) has 15 years of Return on Capital Employed data on record, last reported at 0.63% in Q4 2025.

  • For Q4 2025, Return on Capital Employed rose 115.0% year-over-year to 0.63%; the TTM value through Dec 2025 reached 0.63%, up 115.0%, while the annual FY2025 figure was 0.5%, 97.0% up from the prior year.
  • Return on Capital Employed reached 0.63% in Q4 2025 per NVAX's latest filing, up from 0.38% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 64.22% in Q1 2023 and bottomed at 35.67% in Q2 2023.
  • Average Return on Capital Employed over 5 years is 0.15%, with a median of 0.68% recorded in 2024.
  • Peak YoY movement for Return on Capital Employed: skyrocketed 6707bps in 2023, then crashed -6474bps in 2024.
  • A 5-year view of Return on Capital Employed shows it stood at 9.32% in 2021, then soared by 135bps to 3.27% in 2022, then crashed by -288bps to 6.15% in 2023, then surged by 92bps to 0.52% in 2024, then surged by 222bps to 0.63% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Capital Employed were 0.63% in Q4 2025, 0.38% in Q2 2025, and 0.41% in Q1 2025.